Suppr超能文献

预测人群:评估 2 型糖尿病患者药物治疗不依从风险的新型预测列线图的开发和验证。

Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes.

机构信息

NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, Tianjin, China.

Department of Endocrinology and Metabolism, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia Autonomous Region, China.

出版信息

PeerJ. 2022 Mar 15;10:e13102. doi: 10.7717/peerj.13102. eCollection 2022.

Abstract

BACKGROUND

Diabetes mellitus is a growing global health challenge and affects patients of all ages. Treatment aims to keep blood glucose levels close to normal and to prevent or delay complications. However, adherence to antidiabetic medicines is often unsatisfactory.

PURPOSE

Here, we established and internally validated a medication nonadherence risk nomogram for use in Chinese type 2 diabetes mellitus (T2DM) patients.

METHODS

This cross-sectional study was carried out from July-December 2020 on randomly selected T2DM patients visiting a diabetes clinic and included 753 participants. Adherence was analyzed based on an eight-item Morisky Medication Adherence Scale (MMAS-8). Other data, including patient demographics, treatment, complications, and comorbidities, were also collected on questionnaires. Optimization of feature selection to develop the medication nonadherence risk model was achieved using the least absolute shrinkage and selection operator regression model (LASSO). A prediction model comprising features selected from LASSO model was designed by applying multivariable logistic regression analysis. The decision curve analysis, calibration plot, and -index were utilized to assess the performance of the model in terms of discrimination, calibration, and clinical usefulness. Bootstrapping validation was applied for internal validation.

RESULTS

The prediction nomogram comprised several factors including sex, marital status, education level, employment, distance, self-monitoringofbloodglucose, disease duration, and dosing frequency of daily hypoglycemics (pills, insulin, or glucagon-like peptide-1). The model exhibited good calibration and good discrimination (-index = 0.79, 95% CI [0.75-0.83]). In the validation samples, a high -index (0.75) was achieved. Results of the decision curve analysis revealed that the nonadherence nomogram could be applied in clinical practice in cases where the intervention is decided at a nonadherence possibility threshold of 12%.

CONCLUSION

The number of patients who adhere to anti-diabetes therapy was small. Being single male, having no formal education, employed, far from hospital, long disease duration, and taking antidiabetics twice or thrice daily, had significant negative correlation with medication adherence. Thus, strategies for improving adherence are urgently needed.

摘要

背景

糖尿病是一个日益严重的全球健康挑战,影响着各个年龄段的患者。治疗的目的是将血糖水平保持在接近正常水平,并预防或延缓并发症的发生。然而,抗糖尿病药物的依从性往往不尽如人意。

目的

在这里,我们建立并内部验证了一个适用于中国 2 型糖尿病(T2DM)患者的药物不依从风险诺模图。

方法

这项横断面研究于 2020 年 7 月至 12 月在一家糖尿病诊所随机选择 T2DM 患者进行,共纳入 753 名参与者。根据 Morisky 药物依从性量表(MMAS-8)的八项条目来分析依从性。还通过问卷调查收集了患者的人口统计学、治疗、并发症和合并症等其他数据。使用最小绝对收缩和选择算子回归模型(LASSO)优化特征选择,以开发药物不依从风险模型。通过多变量逻辑回归分析,应用 LASSO 模型中选择的特征设计预测模型。通过决策曲线分析、校准图和 - 指数来评估模型在区分度、校准度和临床实用性方面的性能。Bootstrapping 验证用于内部验证。

结果

预测诺模图包含多个因素,包括性别、婚姻状况、教育水平、就业、距离、自我监测血糖、疾病持续时间和每日低血糖药物(药丸、胰岛素或胰高血糖素样肽-1)的给药频率。该模型具有良好的校准和良好的区分度(-指数=0.79,95%置信区间[0.75-0.83])。在验证样本中,获得了较高的 - 指数(0.75)。决策曲线分析的结果表明,在非依从可能性阈值为 12%的情况下,非依从诺模图可应用于临床实践。

结论

遵守抗糖尿病治疗的患者人数较少。单身男性、未接受正规教育、就业、远离医院、疾病持续时间长以及每天服用抗糖尿病药物两次或三次,与药物依从性呈显著负相关。因此,迫切需要采取提高依从性的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ee/8932313/0676e17ee28c/peerj-10-13102-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验